Literature DB >> 159182

Assessment of a combination of doses of fenoterol and ipratropium suitable for a single metered-dose aerosol.

G J Addis, J Barclay, E M Chang.   

Abstract

This paper reports a study of the bronchodilator effects of doses of the beta 2 agonist fenoterol and the muscarinic blocker ipratropium suitable for administering in combination as a standard dose of two discharges from a single metered-dose pressurised aerosol. In 12 middle-aged bronchitics who had already been shown to respond to both types of drug the combination was almost always a little (6% on average) more effective than either drug singly. It is possible that an equal or better effect could have been obtained if fenoterol or perhaps ipratropium had been given alone in an individually determined maximally effective dose.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 159182     DOI: 10.1007/bf00563114

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  3 in total

1.  Intrapulmonary gas distribution. A comparison of the helium mixing time and nitrogen single breath test in normal and diseased subjects.

Authors:  S Hathirat; A D Renzetti; M Mitchell
Journal:  Am Rev Respir Dis       Date:  1970-11

2.  Ventilatory capacity after bronchodilatation with a new beta-sympathomimetic substance.

Authors:  L Bäcklund; E Fagerberg
Journal:  Scand J Respir Dis       Date:  1968

3.  Comparative trial of a new anticholinergic bronchodilator, Sch 1000, and salbutamol in chronic bronchitis.

Authors:  H Poppius; Y Salorinne
Journal:  Br Med J       Date:  1973-10-20
  3 in total
  2 in total

1.  Effects of ipratropium bromide and fenoterol aerosols in pulmonary emphysema.

Authors:  J A Hughes; M J Tobin; D Bellamy; D C Hutchison
Journal:  Thorax       Date:  1982-09       Impact factor: 9.139

Review 2.  Ipratropium bromide: a review of its pharmacological properties and therapeutic efficacy in asthma and chronic bronchitis.

Authors:  G E Pakes; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1980-10       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.